Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
2.0%
1w
2.2%
1m
6.8%
3m
18.1%
6m
24.2%
1y
37.9%
all
15.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,310 2.0%
1,300
1,645
Company Overview
Sales
1,125 Cr
Growth: 11.7%
Profit after Tax
324 Cr
Growth: -9.0%
Mid Cap
13,702 Cr
P/E: 42.4x
Industry P/E: 32.9x
Fundamentals
Sales (Cr) ₹ 1,125
Growth 11.7%
EBITDA 39.0%
P/S 12.2x
Dividend 0.6%
P/E 42.4x
Book Value ₹ 184
PEG Ratio 3.6x
ROE 17.6%
P/B 7.1x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (18 Indices) view more
Followers (1)
varsha96